Setrobuvir
Alternative Names: AN598; ANA-598; RG 7790; RO 5466731Latest Information Update: 05 Nov 2023
At a glance
- Originator Anadys Pharmaceuticals
- Developer Anadys Pharmaceuticals; Roche
- Class Antivirals; Benzothiadiazines; Small molecules
- Mechanism of Action Hepatitis C virus NS 5 protein inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Hepatitis C
Most Recent Events
- 22 Apr 2015 Discontinued - Phase-I for Hepatitis C (Combination therapy) in Hungary (PO, capsule)
- 22 Apr 2015 Discontinued - Phase-I for Hepatitis C (In volunteers) in Netherlands (PO, tablet & capsule)
- 22 Apr 2015 Discontinued - Phase-II for Hepatitis C (Combination therapy) in USA, Australia, Canada, Germany, New Zealand, Poland and Puerto Rico (PO, capsule)